119 related articles for article (PubMed ID: 37572452)
1. Human papillomavirus-mediated expression of complement regulatory proteins in human cervical cancer cells.
Khan A; Hussain S; Iyer JK; Kaul A; Bonnewitz M; Kaul R
Eur J Obstet Gynecol Reprod Biol; 2023 Sep; 288():222-228. PubMed ID: 37572452
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus E6 protein enriches the CD55(+) population in cervical cancer cells, promoting radioresistance and cancer aggressiveness.
Leung TH; Tang HW; Siu MK; Chan DW; Chan KK; Cheung AN; Ngan HY
J Pathol; 2018 Feb; 244(2):151-163. PubMed ID: 28944962
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of membrane complement inhibitors CD55 and CD59 by siRNA sensitises uterine serous carcinoma overexpressing Her2/neu to complement and antibody-dependent cell cytotoxicity in vitro: implications for trastuzumab-based immunotherapy.
Bellone S; Roque D; Cocco E; Gasparrini S; Bortolomai I; Buza N; Abu-Khalaf M; Silasi DA; Ratner E; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
Br J Cancer; 2012 Apr; 106(9):1543-50. PubMed ID: 22531721
[TBL] [Abstract][Full Text] [Related]
4. Aberrant Hypermethylation of SALL3 with HPV Involvement Contributes to the Carcinogenesis of Cervical Cancer.
Wei X; Zhang S; Cao D; Zhao M; Zhang Q; Zhao J; Yang T; Pei M; Wang L; Li Y; Yang X
PLoS One; 2015; 10(12):e0145700. PubMed ID: 26697877
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity to Fas-mediated apoptosis in high-risk HPV-positive human cervical cancer cells: relationship with Fas, caspase-8, and Bid.
Hougardy BM; van der Zee AG; van den Heuvel FA; Timmer T; de Vries EG; de Jong S
Gynecol Oncol; 2005 May; 97(2):353-64. PubMed ID: 15863130
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of membrane complement inhibitor expression (CD46, CD55, CD59) by siRNA sensitizes tumor cells to complement attack in vitro.
Geis N; Zell S; Rutz R; Li W; Giese T; Mamidi S; Schultz S; Kirschfink M
Curr Cancer Drug Targets; 2010 Dec; 10(8):922-31. PubMed ID: 20879979
[TBL] [Abstract][Full Text] [Related]
7. Investigation of the influence of high-risk human papillomavirus on the biochemical composition of cervical cancer cells using vibrational spectroscopy.
Ostrowska KM; Malkin A; Meade A; O'Leary J; Martin C; Spillane C; Byrne HJ; Lyng FM
Analyst; 2010 Dec; 135(12):3087-93. PubMed ID: 20967345
[TBL] [Abstract][Full Text] [Related]
8. Expression and regulation by interferon-gamma of the membrane-bound complement regulators CD46 (MCP), CD55 (DAF) and CD59 in gastrointestinal tumours.
Schmitt CA; Schwaeble W; Wittig BM; Meyer zum Büschenfelde KH; Dippold WG
Eur J Cancer; 1999 Jan; 35(1):117-24. PubMed ID: 10211099
[TBL] [Abstract][Full Text] [Related]
9. TMEM45A Affects Proliferation, Apoptosis, Epithelial-Mesenchymal Transition, Migration, Invasion and Cisplatin Resistance of HPV-Positive Cervical Cancer Cell Lines.
Liu Y; Liu L; Mou ZX
Biochem Genet; 2022 Feb; 60(1):173-190. PubMed ID: 34143331
[TBL] [Abstract][Full Text] [Related]
10. Arsenic trioxide inhibits cell proliferation and human papillomavirus oncogene expression in cervical cancer cells.
Wang H; Gao P; Zheng J
Biochem Biophys Res Commun; 2014 Sep; 451(4):556-61. PubMed ID: 25117446
[TBL] [Abstract][Full Text] [Related]
11. CRISPR/Cas9 generated human CD46, CD55 and CD59 knockout cell lines as a tool for complement research.
Thielen AJF; van Baarsen IM; Jongsma ML; Zeerleder S; Spaapen RM; Wouters D
J Immunol Methods; 2018 May; 456():15-22. PubMed ID: 29447841
[TBL] [Abstract][Full Text] [Related]
12. Proteasome inhibitor MG132 sensitizes HPV-positive human cervical cancer cells to rhTRAIL-induced apoptosis.
Hougardy BM; Maduro JH; van der Zee AG; de Groot DJ; van den Heuvel FA; de Vries EG; de Jong S
Int J Cancer; 2006 Apr; 118(8):1892-900. PubMed ID: 16287099
[TBL] [Abstract][Full Text] [Related]
13. Novel MicroRNA signatures in HPV-mediated cervical carcinogenesis in Indian women.
Sharma S; Hussain S; Soni K; Singhal P; Tripathi R; Ramachandran VG; Sharma S; Das S; Pillai B; Bharadwaj M
Tumour Biol; 2016 Apr; 37(4):4585-95. PubMed ID: 26508022
[TBL] [Abstract][Full Text] [Related]
14. Long Noncoding RNA loc285194 Expression in Human Papillomavirus-Positive and -Negative Cervical Squamous Cell Carcinoma, C33A, and SiHa Cells and Transforming Growth Factor-β1.
Wang J; Zhang Y; Lin R; Mao B; Wang W; Bai Y; He W; Liu Q
Med Sci Monit; 2019 Nov; 25():9012-9018. PubMed ID: 31774069
[TBL] [Abstract][Full Text] [Related]
15. The inhibitory effect of CD46, CD55, and CD59 on complement activation after immunotherapeutic treatment of cervical carcinoma cells with monoclonal antibodies or bispecific monoclonal antibodies.
Gelderman KA; Blok VT; Fleuren GJ; Gorter A
Lab Invest; 2002 Apr; 82(4):483-93. PubMed ID: 11950905
[TBL] [Abstract][Full Text] [Related]
16. Correlation of p16(INK4A) expression and HPV copy number with cellular FTIR spectroscopic signatures of cervical cancer cells.
Ostrowska KM; Garcia A; Meade AD; Malkin A; Okewumi I; O'Leary JJ; Martin C; Byrne HJ; Lyng FM
Analyst; 2011 Apr; 136(7):1365-73. PubMed ID: 21290054
[TBL] [Abstract][Full Text] [Related]
17. Elevated glucose-6-phosphate dehydrogenase expression in the cervical cancer cases is associated with the cancerigenic event of high-risk human papillomaviruses.
Hu T; Li YS; Chen B; Chang YF; Liu GC; Hong Y; Chen HL; Xiyang YB
Exp Biol Med (Maywood); 2015 Oct; 240(10):1287-97. PubMed ID: 25616277
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of Lonicera japonica-derived exosomal miR2911 on human papilloma virus.
Chi Y; Shi L; Lu S; Cui H; Zha W; Shan L; Shen Y
J Ethnopharmacol; 2024 Jan; 318(Pt B):116969. PubMed ID: 37516391
[TBL] [Abstract][Full Text] [Related]
19. The degradation of Rap1GAP via E6AP-mediated ubiquitin-proteasome pathway is associated with HPV16/18-infection in cervical cancer cells.
Wang Y; Xie Y; Sun B; Guo Y; Song L; Mohammednur DE; Zhao C
Infect Agent Cancer; 2021 Dec; 16(1):71. PubMed ID: 34952616
[TBL] [Abstract][Full Text] [Related]
20. TLR9 expression and its role in chemosensitivity to DDP in human cervical cancer cells in vitro.
Weng Y; Wang Y; Shi Y; Zhou W; Wang H; Wang C
J Huazhong Univ Sci Technolog Med Sci; 2011 Aug; 31(4):550. PubMed ID: 21823020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]